Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration

AIM: To compare the efficacy of intravitreal ranibizumab and bevacizumab for the treatment of neovascular age-related macular degeneration(AMD)using a pro re nata(PRN)treatment regimen.<p>METHODS: A total of 63 eyes(35 eyes treated with ranibizumab and 28 eyes treated with bevacizumab)of 63 pa...

Full description

Bibliographic Details
Main Authors: Huseyin Serdarogullari, Muzaffer Ozturk, Umur Kayhan, Selim Bolukbasi, Burak Erden, Mustafa Elcioglu
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2014-05-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://www.ies.net.cn/cn_publish/2014/5/201405003.pdf